Results 41 to 50 of about 18,164 (153)

Sofosbuvir más glecaprevir/pibrentasvir como terapia de rescate postrasplante hepático en pacientes con exposición previa a inhibidores de NS5A. Serie de casos

Gaceta Médica de México, 2023
Antecedentes: El tratamiento de la infección crónica por el virus de la hepatitis C (VHC) con antivirales de acción directa logra tasas de respuesta virológica sostenida superiores a 95 %.
Ignacio García-Juárez, Carlos Alonzo-García, Alan G. Contreras, Fernanda Romero-Hernández, Maximiliano Servín-Rojas, Alfonso Fernández-Ramírez, Isaac Ruiz   +6 more
doaj   +1 more source

Regulation of TGF-β1, 2, and 3 and IL-10 at systemic level in chronic liver disease

Annals of Hepatology
Introduction and Objectives: Chronic liver disease (CLD) is considered an important health problem worldwide. The production of IL-10 regulated the hepatic inflammation.
Marisela Hernandez-Santillan, Abigail Hernandez-Barragan, Moises Martínez-Castillo, Zaira Medina-Ávila, Harumi Reséndiz-García, Erik Robledo-Ramírez, Yadira Guizar-Alcántara, Amanda Álvarez-Rodea, Danna Mercado-Herrera, María F. Higuera-De La Tijera, José L. Pérez-Hernández, Daniel Santana-Vargas, Gabriela Gutiérrez-Reyes   +12 more
doaj   +1 more source

Mecanismo cinético de la xantinoxidasa de hígado de buey y de la xantindeshidrogenasa de hígado de pollo [PDF]

, 2016
La xantinoxidasa (xantina: oxígeno-oxidorreductasa) fue descubierta por HORBACZEWSKI y SPITZER al observar que la hipoxantina y la xantina, en presencia de varios preparados tisulares, daban lugar a la aparición de ácido úrico, según la secuencia ...
Canela Campos, Enric I. (Enric Isidre), 1949-
core   +6 more sources

CLINICAL CHARACTERISTICS AND SAFETY PROFILE OF ATEZOLIZUMAB/BEVACIZUMAB IN CARCINOMA HEPATOCELLULAR: EXPERIENCE OF A CENTER OF REFERENCE NATIONAL IN PERU

Annals of Hepatology
Introduction and Objectives: The high disease burden and limited survival of cirrhotic patients with hepatocarcinoma have led to the emphasis on the combination of atezolizumab and bevacizumab as first-line therapy.To describe the clinical ...
Jairo Cabanillas Espinoza, Estefania Liza Baca, Javier Diaz Ferrer   +2 more
doaj   +1 more source

COMPARISON OF CXCL-8 and IFN-γ PRODUCTION IN ACUTE AND CHRONIC STAGES OF LIVER DISEASE

Annals of Hepatology, 2022
Introduction and objective: Hepatitis C virus and alcoholism are the main causes of Chronic Liver Disease. (1) The increase of CXCL-8 has been correlated with mortality in alcoholic hepatitis (AH), while in Chronic Hepatitis C (CHC) with the disease ...
I. Altamirano-Mendoza, M. Martínez-Castillo, Z. Medina-Avila, L. García-Islas, J.L. Pérez-Hernández, F. Higuera-De la Tijera, D. Santana-Vargas, J. Cordova-Gallardo, D. Kershenobich, G. Gutiérrez-Reyes   +9 more
doaj   +1 more source

MAFLD/MASLD: Past, Present, and Future

Journal of Gastroenterology and Hepatology, Volume 41, Issue 9, Page 2882-2892, September 2026.
ABSTRACT Metabolic dysfunction‐associated steatotic liver disease (MASLD), also known as nonalcoholic fatty liver disease and metabolic dysfunction‐associated fatty liver disease, affects more than 30% of the global adult population and has become one of the leading causes of cirrhosis and hepatocellular carcinoma.
Vincent Wai‐Sun Wong
wiley   +1 more source

Hígado graso no alcohólico: generalidades

, 2022
El hígado graso no alcohólico se caracteriza por acumulación excesiva de grasa en el hígado, en ausencia de consumo de alcohol en exceso, y otro etiologías como la hepatitis viral crónica y el uso de medicamentos que inducen ...
Rojas Ramos, Perci
core  

¡Un Hígado Equilibrado Es Medio Camino Andado!

, 2020
Important things it does for us, keeping us healthy and alive? Did you know that our dietary habits can affect the wellbeing of our liver? Or that a sedentary lifestyle can harm it? You probably are not aware, but one in every four people in the world
Alemany i Pagès, Mireia, Ramalho-Santos, João, Tavares, Rui, Marisa Azul, Anabela   +3 more
core   +1 more source

Steatotic Liver Disease at Primary Biliary Cholangitis Diagnosis: Association With Ursodeoxycholic Acid Response and Outcomes

Liver International, Volume 46, Issue 7, July 2026.
ABSTRACT Background and Aim Steatotic liver disease (SLD) is becoming increasingly prevalent, leading to a higher frequency of primary biliary cholangitis (PBC) cases coexisting with SLD. However, data on its impact in patients with PBC remain scarce.
María Del Barrio, Margarita Sala, Judith Gómez, Diana Horta, Manuel Hernández‐Guerra, Magdalena Salcedo, Silvia Goñi, Raquel Ríos‐León, Ángela Martínez Herreros, Jesús M. González‐Santiago, Javier Martínez, Nerea C. Quintans, Javier Ampuero, María Dolores Antón, Margarita Fernández‐de la Varga, Desamparados Escudero, Ismael El Hajra, Francisca Cuenca Alarcón, Sara Lorente, Raúl J. Andrade, Mar Riveiro‐Barciela, Inmaculada Castello, Mercè Vergara, Raisa Quiñones, Ana Arencibía Almeida, Sonia Blanco Sampascual, Carles Leal, Montserrat García‐Retortillo, Indhira Pérez‐Medrano, Miguel Fernández‐Bermejo, Rosa M. Morillas, Elena Gómez, Javier Tejedor‐Tejada, Mercè Roget, Sergio Rodríguez‐Tajes, Marta Alonso‐Peña, Ana Álvarez‐Cancelo, María‐Carlota Londoño, Álvaro Díaz‐González   +38 more
wiley   +1 more source

Manejo quirúrgico del quiste hidatídico multivisceral

Anales de la Facultad de Medicina
El quiste hidatídico multivisceral constituye la presencia de quistes hidatidicos en más de un órgano de la cavidad abdominal. Generalmente, requieren manejo quirurgico complejo y tratamiento antiparasitario complementario.
Lucia Fernanda Galarreta-Galvez, Christian Ricardo Zeta-Arica, Cecilia Yeren-Paredes   +2 more
doaj   +1 more source